SUNITINIB Side Effects

6885288-X | Postoperative Renal Failure
on Jul 29, 2010 Male patient from UNITED STATES , weighting 185.2 lb, was diagnosed with renal cancer and was treated with Sunitinib (View Usage). Patient experienced the following unwanted or unexpected effects: postoperative renal failure. Sunitinib dosage: 50mg Once Daily. During the same period patient was treated with ATENOLOL (View Atenolol Review and Atenolol Label ), PRILOSEC (View Prilosec Review and Prilosec Label ), FLONASE (View Flonase Review and Flonase Label ), PLENDIL (View Plendil Review and Plendil Label ). Patient was hospitalized.

6428236-9 | Asthenia, Blood Creatine Phosphokinase Increased, Blood Urea Nitrogen/creatinine Ratio Increased, Diabetic Coma, Myalgia, Palpitations, Spinal Cord Compression
Patient was taking Sunitinib (View Usage). Patient had the following side effects: asthenia, blood creatine phosphokinase increased, blood urea nitrogen/creatinine ratio increased, diabetic coma, myalgia, palpitations, spinal cord compression on Nov 04, 2009 from UNITED STATES Additional patient health information: Male patient , 63 years of age, was diagnosed with renal cell carcinoma and. Sunitinib dosage: 50 Mg Every Day Po. Patient was hospitalized.

6340665-0 | Abdominal Pain Upper, Hypercalcaemia Of Malignancy, Malignant Neoplasm Progression, Pleuritic Pain, Renal Cell Carcinoma
Adverse event was reported on Sep 02, 2009 by a Male patient taking Sunitinib (View Usage) (Dosage: ) . Location: UNITED STATES , 41 years of age, weighting 141.0 lb, After Sunitinib was administered, patient had the following side effects: abdominal pain upper, hypercalcaemia of malignancy, malignant neoplasm progression, pleuritic pain, renal cell carcinoma. During the same period patient was treated with ERLOTINIB (View Erlotinib Review and Erlotinib Label ), HALOPERIDOL (View Haloperidol Review and Haloperidol Label ), LORAZEPAM (View Lorazepam Review and Lorazepam Label ), METOPROLOL (View Metoprolol Review and Metoprolol Label ), METOPROLOL TARTRATE (View Metoprolol Tartrate Review and Metoprolol Tartrate Label ), ZYPREXA (View Zyprexa Review and Zyprexa Label ), OXYCODONE (View Oxycodone Review and Oxycodone Label ), PROCHLORPERAZINE COMPAZINE (View Prochlorperazine -compazine- Review and Prochlorperazine -compazine- Label ). Patient was hospitalized.

6303841-9 | Atrial Fibrillation, Dyspnoea, Fatigue, Left Ventricular Dysfunction, Malaise, Oedema Peripheral
on Aug 07, 2009 Male patient from UNITED STATES , weighting 189.6 lb, was diagnosed with non-small cell lung cancer and was treated with Sunitinib (View Usage). Patient experienced the following unwanted or unexpected effects: atrial fibrillation (What is atrial fibrillation?), dyspnoea, fatigue, left ventricular dysfunction, malaise, oedema peripheral. Sunitinib dosage: 37.5 Mg, Daily, Oral. During the same period patient was treated with ERLOTINIB (150 Mg, Daily, Oral) (View Erlotinib Review and Erlotinib Label ), CHOLECALCIFEROL (View Cholecalciferol Review and Cholecalciferol Label ), METOPROLOL (TOPROL) (View Metoprolol (toprol) Review and Metoprolol (toprol) Label ), HYDROMORPHONE HCL (View Hydromorphone Hcl Review and Hydromorphone Hcl Label ), CLINDAMYCIN (View Clindamycin Review and Clindamycin Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ), DIGOXIN (View Digoxin Review and Digoxin Label ). Patient was hospitalized.


6294864-7 | Atrial Fibrillation, Condition Aggravated, Dyspnoea, Fatigue, Left Ventricular Dysfunction, Malaise, Oedema Peripheral
on Jul 31, 2009 Male patient from UNITED STATES , weighting 189.6 lb, was diagnosed with non-small cell lung cancer and was treated with Sunitinib (View Usage). Patient had the following side effects: atrial fibrillation (What is atrial fibrillation?), condition aggravated, dyspnoea, fatigue, left ventricular dysfunction, malaise, oedema peripheral. Sunitinib dosage: 37.5 Mg, Daily, Oral. During the same period patient was treated with ERLOTINIB (150 Mg, Daily, Oral) (View Erlotinib Review and Erlotinib Label ), CHOLECALCIFEROL (View Cholecalciferol Review and Cholecalciferol Label ), METOPROLOL (TOPROL) (View Metoprolol (toprol) Review and Metoprolol (toprol) Label ), HYDROMORPHONE HCL (View Hydromorphone Hcl Review and Hydromorphone Hcl Label ), CLINDAMYCIN (View Clindamycin Review and Clindamycin Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ), DIGOXIN (View Digoxin Review and Digoxin Label ). Patient was hospitalized.

6283934-5 | Atrial Fibrillation, Cardiac Failure, Condition Aggravated, Left Ventricular Dysfunction, Malaise, Oedema Peripheral
Patient was taking Sunitinib (View Usage). After Sunitinib was administered, patient had the following side effects: atrial fibrillation (What is atrial fibrillation?), cardiac failure, condition aggravated, left ventricular dysfunction, malaise, oedema peripheral on Jul 22, 2009 from UNITED STATES Additional patient health information: Male patient , weighting 189.6 lb, was diagnosed with non-small cell lung cancer and. Sunitinib dosage: 37.5 Mg Daily Oral. During the same period patient was treated with ERLOTINIB (150 Mg Daily Oral) (View Erlotinib Review and Erlotinib Label ). Patient was hospitalized.

6276350-3 | Febrile Neutropenia, Lung Consolidation, Lung Infiltration, Lymphopenia, Opportunistic Infection, Sputum Culture Positive, Staphylococcal Infection
Adverse event was reported on Jul 13, 2009 by a Female patient taking Sunitinib (View Usage) (Dosage: 25 Mg, Qd, Po) was diagnosed with non-small cell lung cancer and. Location: UNITED STATES , 66 years of age, weighting 142.9 lb, Patient experienced the following unwanted or unexpected effects: febrile neutropenia, lung consolidation, lung infiltration, lymphopenia, opportunistic infection, sputum culture positive, staphylococcal infection (What is staphylococcal infection?). During the same period patient was treated with RAPAMYCIN (2 Mg, Qd, Po) (View Rapamycin Review and Rapamycin Label ), METHADONE HCL (View Methadone Hcl Review and Methadone Hcl Label ), REMERON (View Remeron Review and Remeron Label ), SEROQUEL (View Seroquel Review and Seroquel Label ), MIRALAX (View Miralax Review and Miralax Label ), PRILOSEC (View Prilosec Review and Prilosec Label ), ALBUTEROL (View Albuterol Review and Albuterol Label ), ZOFRAN (View Zofran Review and Zofran Label ). Patient was hospitalized.

6276269-8 | Injection Site Infection, Pyrexia
on Jul 20, 2009 Female patient from UNITED STATES , 66 years of age, weighting 117.5 lb, was diagnosed with non-small cell lung cancer and was treated with Sunitinib (View Usage). Patient had the following side effects: injection site infection, pyrexia. Sunitinib dosage: 25 Mg, Qd, Po. During the same period patient was treated with RAPAMYCIN (2 Mg, Qd, Po) (View Rapamycin Review and Rapamycin Label ), CODEINE (View Codeine Review and Codeine Label ), METOPROLOL SUCCINATE (View Metoprolol Succinate Review and Metoprolol Succinate Label ), MULTI VITAMIN (View Multi-vitamin Review and Multi-vitamin Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), RESVERATROL (View Resveratrol Review and Resveratrol Label ), SELENIUM (View Selenium Review and Selenium Label ), SENOKOT (View Senokot Review and Senokot Label ). Patient was hospitalized.

6275045-X | Convulsion, Hyponatraemia, Nausea
on Jul 09, 2009 Male patient from UNITED STATES , 74 years of age, was diagnosed with hypertension and was treated with Sunitinib (View Usage). After Sunitinib was administered, patient had the following side effects: convulsion, hyponatraemia, nausea (What is nausea?). Sunitinib dosage: . During the same period patient was treated with MAXZIDE (View Maxzide Review and Maxzide Label ). Patient was hospitalized.

6249887-0 | Convulsion, Hyponatraemia, Nausea
Patient was taking Sunitinib (View Usage). Patient experienced the following unwanted or unexpected effects: convulsion, hyponatraemia, nausea (What is nausea?) on Jun 19, 2009 from Additional patient health information: Male patient , 74 years of age, was diagnosed with hypertension and. Sunitinib dosage: . During the same period patient was treated with MAXZIDE (View Maxzide Review and Maxzide Label ). Patient was hospitalized.

6246327-2 | Febrile Neutropenia, Lung Consolidation, Lung Infiltration, Lymphopenia, Staphylococcal Infection
Adverse event was reported on Jun 24, 2009 by a Male patient taking Sunitinib (View Usage) (Dosage: 25 Mg, Qd, Po) was diagnosed with non-small cell lung cancer and. Location: UNITED STATES , 66 years of age, weighting 142.9 lb, Patient had the following side effects: febrile neutropenia, lung consolidation, lung infiltration, lymphopenia, staphylococcal infection (What is staphylococcal infection?). During the same period patient was treated with RAPAMYCIN (2 Mg, Qd, Po) (View Rapamycin Review and Rapamycin Label ), METHADONE (View Methadone Review and Methadone Label ), REMERON (View Remeron Review and Remeron Label ), SEROQUEL (View Seroquel Review and Seroquel Label ), MIRALAX (View Miralax Review and Miralax Label ), PRILOSEC (View Prilosec Review and Prilosec Label ), ALBUTEROL (View Albuterol Review and Albuterol Label ), ZOFRAN (View Zofran Review and Zofran Label ). Patient was hospitalized.

6212986-3 | Anaemia, Haematuria
on Jun 02, 2009 Male patient from UNITED STATES , weighting 178.6 lb, was diagnosed with renal cancer metastatic and was treated with Sunitinib (View Usage). After Sunitinib was administered, patient had the following side effects: anaemia, haematuria. Sunitinib dosage: 50 Mg Daily Oral. During the same period patient was treated with ASCORBIC ACID (View Ascorbic Acid Review and Ascorbic Acid Label ), LIDINOPTIL/HCTZ (View Lidinoptil/hctz Review and Lidinoptil/hctz Label ), DOCUSATE SODIUM (View Docusate Sodium Review and Docusate Sodium Label ), ANUSOL HC (View Anusol Hc Review and Anusol Hc Label ), CLARITIN (View Claritin Review and Claritin Label ), TEGRETOL (View Tegretol Review and Tegretol Label ). Patient was hospitalized.

6209881-2 | Abdominal Pain, Blood Albumin Decreased, Chronic Obstructive Pulmonary Disease, Condition Aggravated, Gout, Oedema Peripheral, Proteinuria, Sputum Discoloured
on May 28, 2009 Male patient from UNITED STATES , 65 years of age, weighting 277.4 lb, was diagnosed with neoplasm malignant, palliative care (What is palliative care?) and was treated with Sunitinib (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal pain (What is abdominal pain?), blood albumin decreased, chronic obstructive pulmonary disease, condition aggravated, gout (What is gout?), oedema peripheral, proteinuria, sputum discoloured. Sunitinib dosage: 50 Mg Every Day Po. Patient was hospitalized.

6178021-0 | Acidosis, Acute Respiratory Distress Syndrome, Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Blood Culture Positive, Culture Urine Positive, Haemoglobin Decreased, Hyperglycaemia
Patient was taking Sunitinib (View Usage). Patient had the following side effects: acidosis, acute respiratory distress syndrome, alanine aminotransferase increased, aspartate aminotransferase increased, blood culture positive, culture urine positive, haemoglobin decreased, hyperglycaemia on May 01, 2009 from UNITED STATES Additional patient health information: Male patient , 54 years of age, weighting 80.74 lb, was diagnosed with head and neck cancer (What is head and neck cancer?) and. Sunitinib dosage: 37.5 Mg Daily Po. During the same period patient was treated with RADIATION (View Radiation Review and Radiation Label ), DECADRON (View Decadron Review and Decadron Label ). Patient was hospitalized.

6173827-6 | Asthenia, Cough, Dizziness, Dyspnoea Exertional, Fatigue, Haematochezia, Nausea
Adverse event was reported on Apr 29, 2009 by a Male patient taking Sunitinib (View Usage) (Dosage: 50 Mg Daily Po) was diagnosed with metastatic renal cell carcinoma and. Location: UNITED STATES , 77 years of age, weighting 147.7 lb, After Sunitinib was administered, patient had the following side effects: asthenia, cough, dizziness (What is dizziness?), dyspnoea exertional, fatigue, haematochezia, nausea (What is nausea?).

6150329-4 | Pancreatitis Acute
on Apr 08, 2009 Male patient from UNITED STATES , 72 years of age, was diagnosed with metastatic renal cell carcinoma and was treated with Sunitinib (View Usage). Patient experienced the following unwanted or unexpected effects: pancreatitis acute. Sunitinib dosage: 25 Mg Everyday Po. Patient was hospitalized.

6127663-7 | Atrial Fibrillation
on Mar 19, 2009 Female patient from UNITED STATES , weighting 218.3 lb, was diagnosed with renal cancer and was treated with Sunitinib (View Usage). Patient had the following side effects: atrial fibrillation (What is atrial fibrillation?). Sunitinib dosage: 50 Mg Daily Oral. During the same period patient was treated with VICODIN (View Vicodin Review and Vicodin Label ), SINGULAIR (View Singulair Review and Singulair Label ), FOSAMAX (View Fosamax Review and Fosamax Label ), ADVAIR DISKUS 100/50 (View Advair Diskus 100/50 Review and Advair Diskus 100/50 Label ), ALBUTEROL (View Albuterol Review and Albuterol Label ), FLONASE (View Flonase Review and Flonase Label ), LOVASTATIN (View Lovastatin Review and Lovastatin Label ).

6123956-8 | Atrial Fibrillation
Patient was taking Sunitinib (View Usage). After Sunitinib was administered, patient had the following side effects: atrial fibrillation (What is atrial fibrillation?) on Mar 18, 2009 from UNITED STATES Additional patient health information: Female patient , weighting 218.3 lb, was diagnosed with renal cancer and. Sunitinib dosage: 50 Mg Daily Oral. During the same period patient was treated with VICODIN (View Vicodin Review and Vicodin Label ), SINGULAIR (View Singulair Review and Singulair Label ), FOSAMAX (View Fosamax Review and Fosamax Label ), ADVAIR HFA (View Advair Hfa Review and Advair Hfa Label ), ALBUTEROL (View Albuterol Review and Albuterol Label ), FLONASE (View Flonase Review and Flonase Label ), LOVASTATIN (View Lovastatin Review and Lovastatin Label ).

6097286-7 | Diverticulitis, Intestinal Perforation
Adverse event was reported on Feb 26, 2009 by a Female patient taking Sunitinib (View Usage) (Dosage: 50 Mg Daily Oral) was diagnosed with renal cancer metastatic and. Location: UNITED STATES , weighting 185.2 lb, Patient experienced the following unwanted or unexpected effects: diverticulitis, intestinal perforation. During the same period patient was treated with ARANESP (View Aranesp Review and Aranesp Label ), NORVASC (View Norvasc Review and Norvasc Label ), SYNTHROID (View Synthroid Review and Synthroid Label ), PROTONIX (View Protonix Review and Protonix Label ), COMPAZINE (View Compazine Review and Compazine Label ), ZOFRAN (View Zofran Review and Zofran Label ), BENICAR (View Benicar Review and Benicar Label ). Patient was hospitalized.

6088697-4 | Chills, Leukopenia, Neutropenia, Pyrexia, Thrombocytopenia
on Feb 20, 2009 Male patient from UNITED STATES , 71 years of age, weighting 213.0 lb, was diagnosed with renal cell carcinoma and was treated with Sunitinib (View Usage). Patient had the following side effects: chills, leukopenia, neutropenia, pyrexia, thrombocytopenia. Sunitinib dosage: 50 Mg Every Day Po. Patient was hospitalized.

6083467-5 | Diverticulitis, Intestinal Perforation
on Feb 13, 2009 Female patient from UNITED STATES , weighting 185.2 lb, was diagnosed with renal cancer metastatic and was treated with Sunitinib (View Usage). After Sunitinib was administered, patient had the following side effects: diverticulitis, intestinal perforation. Sunitinib dosage: 50 Mg Daily Oral. During the same period patient was treated with ARANESP (View Aranesp Review and Aranesp Label ), NORVASC (View Norvasc Review and Norvasc Label ), SYNTHROID (View Synthroid Review and Synthroid Label ), PROTONIX (View Protonix Review and Protonix Label ), COMPAZINE (View Compazine Review and Compazine Label ), ZOFRAN (View Zofran Review and Zofran Label ), BENICAR HCT (View Benicar Hct Review and Benicar Hct Label ). Patient was hospitalized.

6075086-1 | Diverticulitis
Patient was taking Sunitinib (View Usage). Patient experienced the following unwanted or unexpected effects: diverticulitis on Feb 10, 2009 from UNITED STATES Additional patient health information: Female patient , weighting 185.2 lb, was diagnosed with renal cancer metastatic and. Sunitinib dosage: 50 Mg Daily Oral. During the same period patient was treated with ARANESP (View Aranesp Review and Aranesp Label ), NORVASC (View Norvasc Review and Norvasc Label ), SYNTHROID (View Synthroid Review and Synthroid Label ), PROTONIX (View Protonix Review and Protonix Label ), COMPAZINE (View Compazine Review and Compazine Label ), ZOFRAN (View Zofran Review and Zofran Label ), BENICAR HCT (View Benicar Hct Review and Benicar Hct Label ). Patient was hospitalized.

6061360-1 | Cancer Pain
Adverse event was reported on Jan 29, 2009 by a Male patient taking Sunitinib (View Usage) (Dosage: 50 Mg Daily Oral) was diagnosed with renal cancer metastatic and. Location: UNITED STATES , weighting 167.6 lb, Patient had the following side effects: cancer pain. During the same period patient was treated with LIPITOR (View Lipitor Review and Lipitor Label ), ZESTRIL (View Zestril Review and Zestril Label ), REGLAN (View Reglan Review and Reglan Label ), PERCOCET (View Percocet Review and Percocet Label ), COMPAZINE (View Compazine Review and Compazine Label ), KYTRIL (View Kytril Review and Kytril Label ), PROTONIX (View Protonix Review and Protonix Label ). Patient was hospitalized.

6050161-6 | Thrombocytopenia
on Jan 21, 2009 Female patient from UNITED STATES , 74 years of age, was diagnosed with vascular operation and was treated with Sunitinib (View Usage). After Sunitinib was administered, patient had the following side effects: thrombocytopenia. Sunitinib dosage: 50 Mg Every Day Po.

6035599-5 | Asthenia, Confusional State, Fall, Heart Rate Increased, Memory Impairment, Nausea, Orthostatic Hypotension, Syncope
on Jan 12, 2009 Male patient from UNITED STATES , 75 years of age, weighting 143.3 lb, was diagnosed with renal cell carcinoma and was treated with Sunitinib (View Usage). Patient experienced the following unwanted or unexpected effects: asthenia, confusional state, fall (What is fall?), heart rate increased, memory impairment, nausea (What is nausea?), orthostatic hypotension, syncope. Sunitinib dosage: 50 Mg Every Day Po. Patient was hospitalized.

6035386-8 | Asthenia, Confusional State, Fall, Heart Rate Increased, Hypophagia, Memory Impairment, Nausea, Orthostatic Hypotension, Syncope
Patient was taking Sunitinib (View Usage). Patient had the following side effects: asthenia, confusional state, fall (What is fall?), heart rate increased, hypophagia, memory impairment, nausea (What is nausea?), orthostatic hypotension, syncope on Jan 12, 2009 from UNITED STATES Additional patient health information: Male patient , 75 years of age, weighting 143.3 lb, was diagnosed with renal cell carcinoma and. Sunitinib dosage: 50 Mg Every Day Po. Patient was hospitalized.

5956964-8 | Leukopenia, Thrombocytopenia
Adverse event was reported on Nov 17, 2008 by a Male patient taking Sunitinib (View Usage) (Dosage: 50 Mg Every Day Po) was diagnosed with renal cell carcinoma and. Location: UNITED STATES , 73 years of age, After Sunitinib was administered, patient had the following side effects: leukopenia, thrombocytopenia. Patient was hospitalized.

5942174-7 | Nausea
on Nov 04, 2008 Female patient from UNITED STATES , 57 years of age, was diagnosed with renal cell carcinoma and was treated with Sunitinib (View Usage). Patient experienced the following unwanted or unexpected effects: nausea (What is nausea?). Sunitinib dosage: 50 Mg Everyday Po.

5942171-1 | Anorexia, Diarrhoea, Fatigue, Glossodynia, Hypophagia, Skin Exfoliation
on Nov 04, 2008 Female patient from UNITED STATES , 75 years of age, was diagnosed with renal cell carcinoma and was treated with Sunitinib (View Usage). Patient had the following side effects: anorexia, diarrhoea, fatigue, glossodynia, hypophagia, skin exfoliation. Sunitinib dosage: 37.5 Mg Every Day Po.

5942074-2 | Abdominal Discomfort, Gastrooesophageal Reflux Disease
Patient was taking Sunitinib (View Usage). After Sunitinib was administered, patient had the following side effects: abdominal discomfort, gastrooesophageal reflux disease on Nov 04, 2008 from UNITED STATES Additional patient health information: Male patient , 62 years of age, . Sunitinib dosage: 500 Mg Every Day Po.

5934479-0 | Confusional State, Dyspnoea, Pyrexia
Adverse event was reported on Oct 21, 2008 by a Male patient taking Sunitinib (View Usage) (Dosage: ) was diagnosed with renal cell carcinoma, nausea (What is nausea?), pain (What is pain?) and. Location: UNITED STATES , weighting 379.2 lb, Patient experienced the following unwanted or unexpected effects: confusional state, dyspnoea, pyrexia. During the same period patient was treated with CP 675,206 (View Cp-675,206 Review and Cp-675,206 Label ), COMPAZINE (View Compazine Review and Compazine Label ), OXYCONTIN (View Oxycontin Review and Oxycontin Label ), PERCOCET (Text:5-325mg 1-2 Tab-freq:q4h Prn) (View Percocet Review and Percocet Label ), NORVASC (View Norvasc Review and Norvasc Label ), AVALIDE (Text:300mg-25mg-freq:one Daily) (View Avalide Review and Avalide Label ), FLOVENT (Text:2 Puffs-freq:twice Daily) (View Flovent Review and Flovent Label ). Patient was hospitalized.

5930755-6 | Eosinophilia, Leukocyturia, Proteinuria, Renal Impairment, Tubulointerstitial Nephritis
on Jan 18, 2008 Female patient from UNITED STATES , 69 years of age, was diagnosed with renal cell carcinoma and was treated with Sunitinib (View Usage). Patient had the following side effects: eosinophilia, leukocyturia, proteinuria, renal impairment, tubulointerstitial nephritis. Sunitinib dosage: Two Courses (cycles). During the same period patient was treated with ATENOLOL (View Atenolol Review and Atenolol Label ), TRIAMTERENE AND HYDROCHLOROTHIAZIDE (View Triamterene And Hydrochlorothiazide Review and Triamterene And Hydrochlorothiazide Label ), AMLODIPINE (View Amlodipine Review and Amlodipine Label ), MULTI VITAMIN (View Multi-vitamin Review and Multi-vitamin Label ). Patient was hospitalized.

5893290-X | Post Procedural Infection, Urinary Tract Infection
on Sep 22, 2008 Male patient from UNITED STATES , weighting 209.0 lb, was diagnosed with renal cell carcinoma and was treated with Sunitinib (View Usage). After Sunitinib was administered, patient had the following side effects: post procedural infection, urinary tract infection (What is urinary tract infection?). Sunitinib dosage: 50 Mg Daily Po. During the same period patient was treated with COLACE (View Colace Review and Colace Label ), FERROUS SULFATE (View Ferrous Sulfate Review and Ferrous Sulfate Label ). Patient was hospitalized.

5885063-9 | Abdominal Pain, Confusional State, Diarrhoea, Diarrhoea Haemorrhagic, Fatigue, Rash, Skin Discolouration, Thrombocytopenia, Weight Decreased
Patient was taking Sunitinib (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal pain (What is abdominal pain?), confusional state, diarrhoea, diarrhoea haemorrhagic, fatigue, rash (What is rash?), skin discolouration, thrombocytopenia, weight decreased on Sep 15, 2008 from UNITED STATES Additional patient health information: Male patient , 65 years of age, weighting 147.7 lb, was diagnosed with renal cell carcinoma and. Sunitinib dosage: 50 Mg Every Day Po. Patient was hospitalized.

5865915-6 | Hypertension, Ventricular Hypokinesia
Adverse event was reported on Aug 20, 2008 by a Female patient taking Sunitinib (View Usage) (Dosage: ) was diagnosed with gastrointestinal stromal tumour and. Location: UNITED STATES , weighting 150.8 lb, Patient had the following side effects: hypertension, ventricular hypokinesia. During the same period patient was treated with MS CONTIN (View Ms Contin Review and Ms Contin Label ), HYGROTON (View Hygroton Review and Hygroton Label ), CAPTOPRIL (View Captopril Review and Captopril Label ), LOPRESSOR (View Lopressor Review and Lopressor Label ), ENALAPRIL MALEATE (View Enalapril Maleate Review and Enalapril Maleate Label ), LASIX (View Lasix Review and Lasix Label ), LANSOPRAZOLE (View Lansoprazole Review and Lansoprazole Label ), ASPIRIN (View Aspirin Review and Aspirin Label ). Patient was hospitalized.

5848075-7 | Fall, Fatigue, Mucosal Inflammation, Pyrexia
on Aug 14, 2008 Female patient from UNITED STATES , weighting 96.89 lb, was diagnosed with head and neck cancer (What is head and neck cancer?) and was treated with Sunitinib (View Usage). After Sunitinib was administered, patient had the following side effects: fall (What is fall?), fatigue, mucosal inflammation, pyrexia. Sunitinib dosage: 37.5mg/daily/po/qd/pill. During the same period patient was treated with NEURONTIN (View Neurontin Review and Neurontin Label ), OXYCODONE HCL (View Oxycodone Hcl Review and Oxycodone Hcl Label ), PREDNISONE TAB (View Prednisone Tab Review and Prednisone Tab Label ), PRILOSEC (View Prilosec Review and Prilosec Label ), NEXIUM (View Nexium Review and Nexium Label ). Patient was hospitalized.

5848071-X | Haemoglobin Decreased, Haemorrhage, Idiopathic Thrombocytopenic Purpura, White Blood Cell Count Decreased
on Aug 14, 2008 Male patient from UNITED STATES , weighting 180.0 lb, was diagnosed with prostate cancer (What is prostate cancer?) and was treated with Sunitinib (View Usage). Patient experienced the following unwanted or unexpected effects: haemoglobin decreased, haemorrhage, idiopathic thrombocytopenic purpura, white blood cell count decreased. Sunitinib dosage: 37.5mg/day/oral/pill. During the same period patient was treated with ORAL ACCUPRIL (View Oral Accupril Review and Oral Accupril Label ), ORAL TRICOR (View Oral Tricor Review and Oral Tricor Label ), ORAL NORVASC (View Oral Norvasc Review and Oral Norvasc Label ), ORAL ASPIRIN (View Oral Aspirin Review and Oral Aspirin Label ), ORAL LIPITOR (View Oral Lipitor Review and Oral Lipitor Label ), HANDIHALER SPIRIVA (View Handihaler Spiriva Review and Handihaler Spiriva Label ), ALBUTEROL (View Albuterol Review and Albuterol Label ). Patient was hospitalized.

5796624-X | Thyroiditis
Patient was taking Sunitinib (View Usage). Patient had the following side effects: thyroiditis on Jun 30, 2008 from UNITED STATES Additional patient health information: Male patient , 76 years of age, weighting 145.0 lb, was diagnosed with renal cell carcinoma and. Sunitinib dosage: 50 Mg Every Day Po.

5789113-X | Disease Progression, Dyspnoea, Metastasis, Pleural Effusion
Adverse event was reported on Jun 25, 2008 by a Male patient taking Sunitinib (View Usage) (Dosage: 50 Mg Qd Po) was diagnosed with renal cancer metastatic and. Location: UNITED STATES , weighting 158.7 lb, After Sunitinib was administered, patient had the following side effects: disease progression, dyspnoea, metastasis, pleural effusion. During the same period patient was treated with OXYCONTIN (View Oxycontin Review and Oxycontin Label ), OXYCODONE HCL (View Oxycodone Hcl Review and Oxycodone Hcl Label ), M.V.I. (View M.v.i. Review and M.v.i. Label ), NORVASC (View Norvasc Review and Norvasc Label ), ATACAND (View Atacand Review and Atacand Label ), LIPITOR (View Lipitor Review and Lipitor Label ). Patient was hospitalized.

5763970-5 | Dyspnoea, Malignant Pleural Effusion
on Jun 06, 2008 Male patient from UNITED STATES , weighting 158.7 lb, was diagnosed with renal cancer metastatic and was treated with Sunitinib (View Usage). Patient experienced the following unwanted or unexpected effects: dyspnoea, malignant pleural effusion. Sunitinib dosage: 50 Mg Qd Po. During the same period patient was treated with OXYCONTIN (View Oxycontin Review and Oxycontin Label ), OXYCODONE HCL (View Oxycodone Hcl Review and Oxycodone Hcl Label ), M.V.I. (View M.v.i. Review and M.v.i. Label ), NORVASC (View Norvasc Review and Norvasc Label ), ATACAND (View Atacand Review and Atacand Label ), LIPITOR (View Lipitor Review and Lipitor Label ). Patient was hospitalized.

5755696-9 | Coma, Hypoglycaemia
on May 30, 2008 Male patient from UNITED STATES , 53 years of age, weighting 260.1 lb, was diagnosed with renal cell carcinoma and was treated with Sunitinib (View Usage). Patient had the following side effects: coma, hypoglycaemia. Sunitinib dosage: 50 Mg Every Day Po.

5743297-8 | Syncope
Patient was taking Sunitinib (View Usage). After Sunitinib was administered, patient had the following side effects: syncope on May 08, 2008 from UNITED STATES Additional patient health information: Female patient , weighting 143.1 lb, was diagnosed with breast cancer metastatic and. Sunitinib dosage: . During the same period patient was treated with CADUET (View Caduet Review and Caduet Label ), METOPROLOL TARTRATE (View Metoprolol Tartrate Review and Metoprolol Tartrate Label ), ISOSORBIDE DINITRATE (View Isosorbide Dinitrate Review and Isosorbide Dinitrate Label ), ACETYLSALICYLIC ACID SRT (View Acetylsalicylic Acid Srt Review and Acetylsalicylic Acid Srt Label ), POTASSIUM CHLORIDE (View Potassium Chloride Review and Potassium Chloride Label ), PROMETHAZINE (View Promethazine Review and Promethazine Label ), ZOFRAN (View Zofran Review and Zofran Label ). Patient was hospitalized.

5669755-2 | Dizziness
Adverse event was reported on Mar 13, 2008 by a Male patient taking Sunitinib (View Usage) (Dosage: 50 Mg Daily Oral) was diagnosed with renal cancer metastatic and. Location: UNITED STATES , weighting 238.1 lb, Patient experienced the following unwanted or unexpected effects: dizziness (What is dizziness?). During the same period patient was treated with PEPCID (View Pepcid Review and Pepcid Label ), LOPERAMIDE HCL (View Loperamide Hcl Review and Loperamide Hcl Label ), SYNTHROID (View Synthroid Review and Synthroid Label ), COMPAZINE (View Compazine Review and Compazine Label ), KYTRIL (View Kytril Review and Kytril Label ). Patient was hospitalized.

5669308-6 | Abdominal Pain, Disease Progression, Pleural Effusion
on Mar 13, 2008 Male patient from UNITED STATES , weighting 121.3 lb, was diagnosed with renal cancer metastatic and was treated with Sunitinib (View Usage). Patient had the following side effects: abdominal pain (What is abdominal pain?), disease progression, pleural effusion. Sunitinib dosage: 50 Mg Daily Oral. During the same period patient was treated with SYNTHROID (View Synthroid Review and Synthroid Label ), PEPCID (View Pepcid Review and Pepcid Label ), SENNA PLUS (View Senna Plus Review and Senna Plus Label ), PREPARATION H OINTMENT (View Preparation H Ointment Review and Preparation H Ointment Label ), BIAFINE EMULSION TOPICAL (View Biafine Emulsion Topical Review and Biafine Emulsion Topical Label ), NYSTATIN (View Nystatin Review and Nystatin Label ), LIDOCAINE HCL VISCOUS (View Lidocaine Hcl Viscous Review and Lidocaine Hcl Viscous Label ). Patient was hospitalized.

5669307-4 | Adenocarcinoma, Disease Progression, Flank Pain, Malignant Pleural Effusion, Metastatic Neoplasm
on Mar 13, 2008 Female patient from UNITED STATES , weighting 152.8 lb, was diagnosed with renal cancer metastatic and was treated with Sunitinib (View Usage). After Sunitinib was administered, patient had the following side effects: adenocarcinoma, disease progression, flank pain, malignant pleural effusion, metastatic neoplasm. Sunitinib dosage: 37.5 Mg Daily Oral. During the same period patient was treated with NICODERM (View Nicoderm Review and Nicoderm Label ), PERCOCET (View Percocet Review and Percocet Label ), SENNA (View Senna Review and Senna Label ), COMBIVENT (View Combivent Review and Combivent Label ), PRILOSEC (View Prilosec Review and Prilosec Label ), XYLOCAINE VISCOUS (View Xylocaine Viscous Review and Xylocaine Viscous Label ), TYLENOL (CAPLET) (View Tylenol (caplet) Review and Tylenol (caplet) Label ). Patient was hospitalized.

5659351-5 | Asthenia, Cerebrovascular Accident, Convulsion, Lethargy, Neoplasm Progression, Speech Disorder
Patient was taking Sunitinib (View Usage). Patient experienced the following unwanted or unexpected effects: asthenia, cerebrovascular accident, convulsion, lethargy, neoplasm progression, speech disorder on Mar 06, 2008 from UNITED STATES Additional patient health information: Male patient , weighting 171.0 lb, was diagnosed with metastases to central nervous system, non-small cell lung cancer and. Sunitinib dosage: 37.5mg/daily/oral/pill. During the same period patient was treated with ADVAIR DISKUS 100/50 (View Advair Diskus 100/50 Review and Advair Diskus 100/50 Label ), DECADRON (View Decadron Review and Decadron Label ), KEPPRA (View Keppra Review and Keppra Label ), PEPCID (View Pepcid Review and Pepcid Label ), TYLENOL (CAPLET) (View Tylenol (caplet) Review and Tylenol (caplet) Label ). Patient was hospitalized.

5659344-8 | Haemoglobin Decreased, Heparin-induced Thrombocytopenia, Mouth Haemorrhage
Adverse event was reported on Mar 06, 2008 by a Male patient taking Sunitinib (View Usage) (Dosage: 37.5mg/day/oral/pill) was diagnosed with prostate cancer (What is prostate cancer?) and. Location: UNITED STATES , weighting 180.0 lb, Patient had the following side effects: haemoglobin decreased, heparin-induced thrombocytopenia, mouth haemorrhage. During the same period patient was treated with ACCUPRIL (View Accupril Review and Accupril Label ), TRICOR (View Tricor Review and Tricor Label ), NORVASC (View Norvasc Review and Norvasc Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), LIPITOR (View Lipitor Review and Lipitor Label ), HANDIHALER SPIRIVA (View Handihaler Spiriva Review and Handihaler Spiriva Label ), ALBUTEROL (View Albuterol Review and Albuterol Label ), PROLOSEC (View Prolosec Review and Prolosec Label ). Patient was hospitalized.

5654633-5 | Dehydration, Infection
on Mar 07, 2008 Female patient from UNITED STATES , weighting 94.20 lb, was diagnosed with neoplasm malignant and was treated with Sunitinib (View Usage). After Sunitinib was administered, patient had the following side effects: dehydration, infection (What is infection?). Sunitinib dosage: 37.5mg/daily/oral/pill. During the same period patient was treated with NEURONTIN (View Neurontin Review and Neurontin Label ), OXYCODONE HCL (View Oxycodone Hcl Review and Oxycodone Hcl Label ), PREDNISONE (View Prednisone Review and Prednisone Label ), PRILOSEC + NEXIUM (View Prilosec + Nexium Review and Prilosec + Nexium Label ). Patient was hospitalized.

5648722-9 | Cardiac Arrest, Dehydration, Failure To Thrive, Lymphadenopathy, Mucosal Inflammation, Pain, Pericardial Effusion, Pneumonia Aspiration, Respiratory Failure
on Mar 03, 2008 Female patient from UNITED STATES , weighting 114.0 lb, was diagnosed with neoplasm malignant and was treated with Sunitinib (View Usage). Patient experienced the following unwanted or unexpected effects: cardiac arrest (What is cardiac arrest?), dehydration, failure to thrive, lymphadenopathy, mucosal inflammation, pain (What is pain?), pericardial effusion, pneumonia aspiration, respiratory failure. Sunitinib dosage: 37.5mg/ Day/ Oral/ Pill. During the same period patient was treated with NEURONTIN (View Neurontin Review and Neurontin Label ), OXYCODONE HCL (View Oxycodone Hcl Review and Oxycodone Hcl Label ), PREDNISONE TAB (View Prednisone Tab Review and Prednisone Tab Label ), PRILOSEC (View Prilosec Review and Prilosec Label ), NEXIUM (View Nexium Review and Nexium Label ). Patient was hospitalized.

5648717-5 | Dyspnoea
Patient was taking Sunitinib (View Usage). Patient had the following side effects: dyspnoea on Mar 03, 2008 from UNITED STATES Additional patient health information: Male patient , 81 years of age, was diagnosed with gastrointestinal stromal tumour, prostate cancer (What is prostate cancer?) and. Sunitinib dosage: 50mg Every Day Po. Patient was hospitalized.